Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07214909 · ClinicalTrials.gov registry record · NA
Gastric POCUS Clear Liquids
A NA study, sponsored by MetroHealth Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07214909: Completed NA study, sponsored by MetroHealth Medical Center.
NCT07214909 is a NA study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07214909, a NA study, has completed, sponsored by MetroHealth Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
To determine the gastric emptying time for clear liquids at different volumes in the adult population, for use in determining anesthesia guidelines.
Interventions
- OTHER Ingesting coffee without creamer
- OTHER Ingesting coffee with creamer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-01-18 |
| Est. Completion | 2024-12-09 |
| Phase | NA |
What the finished NCT07214909 record still lists
NCT07214909 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Ingesting coffee without creamer is the first listed.
NCT07214909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07214909 about?
NCT07214909 is a clinical study titled "Gastric POCUS Clear Liquids". To determine the gastric emptying time for clear liquids at different volumes in the adult population, for use in determining anesthesia guidelines.
What is the current status of trial NCT07214909?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2023-01-18. Estimated completion is 2024-12-09.
What interventions are being tested in trial NCT07214909?
The interventions under investigation include: Ingesting coffee without creamer (OTHER), Ingesting coffee with creamer (OTHER).
Who is sponsoring clinical trial NCT07214909?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07214909's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI